GVR Report cover Pharmaceutical Glass Packaging Market Size, Share & Trends Report

Pharmaceutical Glass Packaging Market Size, Share & Trends Analysis Report By Product (Vials, Bottles, Cartridges & Syringes, Ampoules), By Drug Type (Generic, Branded, Biologic), By Region, And Segment Forecasts, 2021 - 2028

  • Report ID: GVR-2-68038-175-7
  • Number of Pages: 208
  • Format: Electronic (PDF)

Report Overview

The global pharmaceutical glass packaging market size was valued at USD 3.79 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 8.8% from 2021 to 2028. Extensive utilization of generic injectable drugs, coupled with the high demand from the pharmaceutical industry, is anticipated to drive the market. Glass poses as a hindrance to atmospheric gases, such as carbon dioxide and oxygen, from entering the primary container, mitigating the risk of contamination of the drugs. Glass packaging lowers the drug’s susceptibility to degradation, such as hydrolysis and oxidation. Moreover, glass packaging helps in resisting the escape of volatile ingredients, thereby increasing the drug stability. All these factors are anticipated to surge the product demand in the near future.

U.S. pharmaceutical glass packaging market size, by product, 2018 - 2028 (USD Million)

The growth in the global pharma market slowed considerably in 2017 due to the slow growth of the industry in emerging markets owing to low to moderate demand for pharmaceutical products. This was seen particularly in the case of the U.S., which is the world’s largest and the most important pharmaceuticals market. The sales of injection drugs were majorly affected within the market. However, the growing importance of generic drugs and access to better healthcare services in the economy are anticipated to provide opportunities for the market.

The growing significance of cost-sensitivity and biotech drugs in the healthcare sector has resulted in the establishment of strict regulations related to drug delivery products. Multiple manufacturers working in the pharmaceutical glass manufacturing market are focused on packaging aimed at increasing the shelf life of a product and are therefore investing in vials.

The pharmaceutical glass packaging developers have been enhancing their production capabilities in order to cater to the changing pharmaceutical industry, which is anticipated to incline more toward biological drugs. Gerresheimer AG, for instance, has developed a metal-free 1 ml Gx RTF long Luer Lock syringe. This syringe uses a new technology in which the pin used to shape the cone is made of a special ceramic material instead of the conventional tungsten or alternative metal.

The additional impact of the COVID-19 pandemic has left the pharmaceutical industry with a steadily growing high demand for medicines and other healthcare facilities. The surge in demand for pharmaceutical drugs, as a result of the pandemic, has affected the market growth positively. The demand is expected to reach a new peak in the case of the approval for COVID-19 vaccines developed by different institutions and companies in various countries.

Product Insights

Bottles held the largest share of 35.1% in terms of revenue in 2020. The market has been segmented on the basis of product as ampoules, bottles, vials, and syringes and cartridges. Vials are expected to expand at the second-fastest revenue-based CAGR after ampoules from 2021 to 2028 owing to their high analytical performance and great sustainability. Vials are made from Type 1 borosilicate glass, which imparts the desired chemical resistance properties to the glass vials.

Glass bottles used for pharmaceutical packaging are categorized into two types depending on the size, namely small bottles and large bottles. The large size glass bottles are used for the packaging of reagents as well as transfusion and infusion bottles. The small glass bottles are used for the packaging of syrup bottles and other oral liquids. The small-sized bottles segment is expected to witness growth on account of numerous new opportunities, including the rising consumption of oral tablets that are packaged in small bottles.

Ampoules accounted for the largest volume share of 74.7% in 2020 owing to their better analytical performance and suitability. Ampoules that are largely developed from glass are expected to witness the fastest growth over the forecast period, both in terms of revenue and volume, owing to the ability of glass to filter specific wavelengths, high microbiological control, and high chemical resistance. A large number of ampoules are produced in compliance with the DIN ISO EN 9187-1/2 standard in sealed designs, funnel-type, and straight-stem.

Drug Type Insights

The generic drug type segment led the market and accounted for 71.2% share of the global revenue in 2020. The global market for generic drugs has witnessed growth in the past several years due to the increasing cases of chronic diseases, the aging population, and the rise in the expiration of drug patents. Furthermore, the efforts from governments and health care service providers to reduce the healthcare expenditure and drug prices and the provision of health insurance coverage are anticipated to fuel the consumption of generic drugs. The increased consumption of generics is expected to ascend the demand for pharmaceutical glass packaging owing to its regulatory ease and extraordinary barrier property.

Global pharmaceutical glass packaging market share, by drug type, 2020 (%)

The growth of the biologic drug type segment is majorly due to the ability of biologic drugs to treat major chronic diseases, especially certain forms of autoimmune diseases and cancer. However, glass delamination and chipping that result from surface degradation are anticipated to lower the growth of primary glass packaging for biologic drugs.

The generic drug type segment in North America is expected to witness higher growth than the branded drug type segment, both in terms of volume and revenue, as it is affordable, whereas the patent expirations are further going to lead the branded segment to expand at a moderate growth rate. The primary glass packaging is expected to witness sluggish growth on account of decreased volume sales of branded drugs.

In terms of revenue, six biologic drugs accounted for the top ten in 2016. The pharmaceutical industry is expected to largely benefit from biologics as they cater to therapeutic aspects that are underserved. The biosimilar competition for biologics has remained low resulting in the moderate growth of the segment, thereby slowing the growth of the segment in the market.

The U.S. boasts the presence of pharmaceutical giants and therefore is expected to stay a core region for various business activities related to pharmaceutical glass packaging. The customer consolidation and increased competitive intensity in the country are expected to result in a significant increase in the volume of generic drug sales, thus causing rapid change in market dynamics. This change, coupled with patent expirations of numerous drugs, is expected to constrain the branded product sales in the U.S.

Regional Insights

North America dominated the market and accounted for a 36.5% share of the global revenue in 2020. The developing markets are expected to witness a surge in spending on the pharmaceutical industry over the upcoming years. The U.S. is expected to remain a key driver and most important market for the growth of the pharmaceutical sector in the region with innovative products leading the growth. This growth is expected to be aided by the rise in generics in the region that are anticipated to witness consistently high demand in terms of volume and sales.

Emerging markets are expected to witness higher growth compared to developed markets due to the rapid expansion of the consumer base and increase in spending. Increased cases of chronic ailments, increased healthcare awareness, and rising income levels are expected to further aid the growth of emerging markets in the Asia Pacific. The governments in the Asia Pacific region are expanding their private and public healthcare coverage as a result of the increased awareness. The efforts of the government in developing regions to promote low-cost generic drugs and reduce healthcare costs are expected to result in the increased volume of pharmaceutical products, further fueling the growth of the market in the region.

Asia Pacific is anticipated to be the fastest-growing regional market in terms of revenue as well as volume over the forecast period. This growth can be attributed to the presence of numerous small and medium scaled production units in the region. The region also enjoys lenient regulatory regimes, which help in supporting the manufacturers, along with attracting foreign investment. Usually, companies like Corning and Schott AG partners up with small-scale production units in the region, which provides them a platform to expand their regional presence along with gaining a higher share in the market.

The European region accounted for an 18.1% share of the overall volume in 2020. The research-based pharmaceutical industry is a key asset of the European economy. The pharmaceutical glass packaging industry is on the rise owing to the growth in medical progress by means of research, development, and introduction of new medicines aimed at improving the health and quality of life of patients in the region. The national regulation that holds down prices and profits and results in market fragmentation is anticipated to be a major factor that differentiates the strengths of the European research-based industry and its American counterparts in the pharmaceutical sector.

Key Companies & Market Share Insights

Numerous pharmaceutical glass manufacturing companies are primarily concentrated in the developed regions such as Europe and North America, resulting in a well-established supply chain and production system in the regions. However, manufacturers are shifting their bases to countries, such as Brazil, India, and China, due to low labor costs and the growth opportunities offered by these countries. The generic drug sector in particular is expected to drive the demand for pharmaceutical glass packaging in these countries over the forecast period.

Players including SGD S.A. and ÅžiÅŸecam Group are considered emerging players in the global market. This is due to the continuous investments in the expansion of the business and the production of glass pharma packaging. For instance, SGD S.A. has been upgrading its plants in China and Spain with advanced equipment in order to boost production. In August 2018, the company had invested approximately USD 7.8 million to rebuild the furnace and has boosted production by 11%. Some prominent players in the global pharmaceutical glass packaging market include:

  • Corning Incorporated

  • Nipro Corporation

  • SGD S.A.

  • Stölzle-Oberglas GmbH

  • Bormioli Pharma S.r.l

  • West Pharmaceutical Services, Inc.

  • Schott AG

  • Gerresheimer AG

  • Shandong Medicinal Glass Co., Ltd.

  • Beatson Clark

  • Ardagh Group S.A.

  • Arab Pharmaceutical Glass Co.

  • Piramal Enterprises Ltd.

  • ÅžiÅŸecam Group

  • Owens-Illinois, Inc.

Pharmaceutical Glass Packaging Market Report Scope

Report Attribute


Market size value in 2021

USD 4.02 billion

Revenue forecast in 2028

USD 7.46 billion

Growth Rate

CAGR of 8.8% from 2021 to 2028

Base year for estimation


Historical data

2017 - 2019

Forecast period

2021 - 2028

Quantitative units

Revenue in USD million/billion, volume in million units, CAGR from 2021 to 2028

Report coverage

Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Product, drug type, region

Regional scope

North America; Europe; Asia Pacific; Central & South America; Middle East & Africa

Country scope

U.S.; Canada; Mexico; U.K.; Germany; France; Italy; Spain; China; Japan; India; South Korea; Australia; Brazil; Saudi Arabia

Key companies profiled

Corning Incorporated; Nipro Corporation; SGD S.A.; Stölzle-Oberglas GmbH; Bormioli Pharma S.r.l; West Pharmaceutical Services, Inc.; Schott AG; Gerresheimer AG; Shandong Medicinal Glass Co., Ltd.; Beatson Clark; Ardagh Group S.A.; Arab Pharmaceutical Glass Co.; Piramal Enterprises Ltd.; ÅžiÅŸecam Group; Owens-Illinois, Inc.

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Segments Covered in the Report

This report forecasts revenue and volume growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2017 to 2028. For the purpose of this study, Grand View Research has segmented the global pharmaceutical glass packaging market report on the basis of product, drug type, and region:

  • Product Outlook (Volume, Million Units; Revenue, USD Million, 2017 - 2028)

    • Vials

      • Small vials

      • Large vials

    • Bottles

      • Small bottles

      • Large bottles

    • Cartridges & Syringes

    • Ampoules

  • Drug Type Outlook (Volume, Million Units; Revenue, USD Million, 2017 - 2028)

    • Generic

    • Branded

    • Biologic

  • Regional Outlook (Volume, Million Units; Revenue, USD Million, 2017 - 2028)

    • North America

      • U.S.

      • Canada

      • Mexico

    • Europe

      • U.K.

      • Germany

      • France

      • Italy

      • Spain

    • Asia Pacific

      • China

      • Japan

      • India

      • South Korea

      • Australia

    • Central & South America (CSA)

      •  Brazil

    • Middle East & Africa (MEA)

      • Saudi Arabia

Frequently Asked Questions About This Report

gvr icn


gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

D&B icon

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.